Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy?
Cancer
.
2016 May 1;122(9):1461-2.
doi: 10.1002/cncr.29943.
Epub 2016 Mar 11.
Authors
Andrea Tendas
1
,
Luca Cupelli
1
,
Maria Rita Mauroni
2
,
Fabio Sollazzo
1
,
Fabio Di Piazza
2
,
Debora Saltarelli
3
,
Ilaria Carli
3
,
Anna Chierichini
3
,
Chiara Melfa
4
,
Maria Antonietta Surano
4
,
Ombretta Annibali
4
,
Monica Piedimonte
1
,
Esmeralda Conte
5
,
Francesco Marchesi
6
,
Caterina Viggiani
6
,
Adriana Concetta Pignatelli
6
,
Teresa Dentamaro
1
,
Paolo de Fabritiis
1
,
Alessio Pio Perrotti
1
,
William Arcese
2
;
Quality of Life Working Party of the Rome Transplant Network
Affiliations
1
Department of Hematology, S. Eugenio Hospital, Rome, Italy.
2
Stem Cell Transplant Unit, Department of Hematology, Tor Vergata University, Rome, Italy.
3
Department of Hematology, S. Giovanni Addolorata Hospital, Rome, Italy.
4
Department of Hematology, University Campus Bio-Medico, Rome, Italy.
5
Department of Hematology, S. Andrea Hospital, Rome, Italy.
6
Department of Hematology, Regina Elena National Cancer Institute, Rome, Italy.
PMID:
26970196
DOI:
10.1002/cncr.29943
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Outcome Assessment, Health Care
Patient Reported Outcome Measures*
Quality of Life*